Seres Therapeutics, Inc. (MCRB)
15.15
+0.27
(+1.81%)
USD |
NASDAQ |
Jan 02, 16:00
15.21
+0.06
(+0.40%)
After-Hours: 20:00
Seres Therapeutics Market Cap: 132.63M for Jan. 2, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Altimmune, Inc. | 366.24M |
| NovaBay Pharmaceuticals, Inc. | 739.68M |
| Palatin Technologies, Inc. | 14.92M |
| Theriva Biologics, Inc. | 8.705M |
| Oragenics, Inc. | 0.6871M |
Market Cap Related Metrics
| PE Ratio | 24.95 |
| PS Ratio | 376.38 |
| Price to Book Value | 3.035 |
| Price | 15.15 |
| Earnings Yield | 4.01% |
| Normalized PE Ratio | 24.96 |